Rheumatoid FAQ

Rheumatoid Arthritis and COVID-19: Understanding the Connection and Risks

People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19, the novel coronavirus that has caused the current worldwide pandemic. COVID-19 is a highly infectious virus that spreads through airborne respiratory droplets. Managing rheumatoid arthritis during COVID-19 is crucial for patients. Living With RA: How to Protect Yourself From COVID-19 – WebMD

Reactive arthritis is also a concern, being relatively common after certain infections, now including SARS-CoV-2, the virus that causes COVID-19. Reactive arthritis involves joint pain and inflammation. Reactive Arthritis Following COVID-19 Infection: What to Know – Healthline

If you have RA, it’s important to take extra steps to protect against COVID-19, as you may have a higher risk for getting the virus or developing severe symptoms. Coronavirus and Rheumatoid Arthritis: Is There a Connection? – Healthline

Studies have reported autoantibodies in patients with COVID-19, including anti-cardiolipin, anti-β2-glycoprotein I, and antinuclear antibodies. The occurrence of Anti-citrullinated protein antibodies (ACPA) and flaring of rheumatoid arthritis (RA) after SARS-Cov-2 infection has also been described. COVID-19 and rheumatoid arthritis – PubMed

Rheumatoid arthritis (RA) is the most common immune-mediated disorder in COVID-19 patients. This review discusses how commonly used drugs in RA alter the patients’ susceptibility to this infection and summarizes the recommendations from major bodies on managing this disease in these times. Onset of rheumatoid arthritis after COVID-19: coincidence or connected – BMJ

For those with RA, it’s crucial to understand the risks and protections regarding COVID-19. RA & Vaccinations During COVID – Arthritis Foundation

In patients with RA, risk factors for severe COVID-19 outcomes include older age and comorbidities similar to those in the general population. Glucocorticoids, but not other classes of disease-modifying antirheumatic drugs (DMARDs), appear to be associated with a higher risk of severe COVID-19 outcomes. Rheumatoid Arthritis and COVID-19: Risks, Research, and More – Healthline

Becker

Recent Posts

Understanding Chest Pain: Is It a Heart Issue or Something Else?

Chest pain is a common symptom that can be caused by a variety of conditions,…

5 months ago

Understanding Neck Pain: Causes, Symptoms, and Treatment Options

Neck pain, also known as cervicalgia, is a common problem, with two-thirds of the population…

5 months ago

Understanding Sinusitis: Causes, Symptoms, and Treatment Options

Sinusitis, also known as rhinosinusitis, is an inflammation of the mucous membranes that line the…

5 months ago

Understanding the Causes and Seriousness of Neck Pain

Neck pain, also known as cervicalgia, is a common issue affecting two-thirds of the population…

5 months ago

Understanding Persistent Neck Pain: Causes and Solutions

Neck pain, also known as cervicalgia, is a widespread issue, affecting two-thirds of the population…

5 months ago

Understanding Neck Pain: Causes, Symptoms, and Treatment Options

Neck pain, also known as cervicalgia, is a widespread issue, with a significant portion of…

5 months ago